Evidence map›Paper›PMID 29264718›Full record

Trial reportParasitology research2018

Resistance to trypanocidal drugs in cattle populations of Zambezia Province, Mozambique.

Fernando Chanisso Mulandane, José Fafetine, Jan Van Den Abbeele, Peter-Henning Clausen, Antje Hoppenheit, Giuliano Cecchi, Marinda Oosthuizen, Vincent Delespaux, Luis Neves

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Parasitology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.International journal for parasitology. Drugs and drug resistance · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fernando Chanisso MulandaneBiotechnology Center (CB-UEM-Mozambique), Eduardo Mondlane University, Maputo, Mozambique. chanisso@yahoo.com.br.
José FafetineBiotechnology Center (CB-UEM-Mozambique), Eduardo Mondlane University, Maputo, Mozambique.
Jan Van Den AbbeeleInstitute of Tropical Medicine Antwerp (ITM-Belgium), Antwerp, Belgium.
Peter-Henning ClausenFreie Universitaet Berlin, Institute of Parasitology and Tropical Veterinary Medicine, Berlin, Germany.
Antje HoppenheitFreie Universitaet Berlin, Institute of Parasitology and Tropical Veterinary Medicine, Berlin, Germany.
Giuliano CecchiFood and Agriculture Organization of the United Nations, Sub-Regional Office for Eastern Africa, Addis Ababa, Ethiopia.
Marinda OosthuizenDepartment of Veterinary Tropical Diseases, Vectors and Vector Borne Diseases Research Program, University of Pretoria (UP-South Africa), Pretoria, South Africa.
Vincent DelespauxBio-engineering Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Luis NevesBiotechnology Center (CB-UEM-Mozambique), Eduardo Mondlane University, Maputo, Mozambique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African animal trypanosomosis is a debilitating tsetse-transmitted parasitic disease of sub-Saharan Africa. Therapeutic and prophylactic drugs were introduced more than 50 years ago, and drug resistance is increasingly reported. In a cross-sectional study, 467 cattle were microscopically screened for trypanosomes. Samples were collected in May-July 2014 from five villages (Botao, Mungama, Zalala-Electrosul, Zalala-Madal, and Namitangurine) in Nicoadala district, Zambezia province. To evaluate treatment efficacy, trypanosome-positive animals in each village were randomly assigned to two groups, one treated with 0.5 mg/kg b.w. isometamidium (Inomidium®), the second with 3.5 mg/kg b.w. diminazene (Inomazene®). Cattle were microscopically monitored at days 0, 14, and 28 post-treatment. At day 28, trypanocides were swapped to investigate single or multiple resistance. Microscopically negative samples from the monitoring days were tested using 18S-PCR-RFLP. 22.9% (107/467) was found positive on day 0. On day 14, nine animals in Botao and seven in Mungama were positive. On day 28, in Botao, four animals from the diminazene group and four from the isometamidium group were positive. In Mungama, four animals from the diminazene group were positive on day 28. On day 42, six animals (9%) in Botao and two (9.5%) in Mungama remained positive after drug swap. No relapses occurred in Namitangurine. The 18S-PCR-RFLP consistently detected more positive than microscopy: indeed, positives reached 12, 13, and 8 in Botao and 9, 7, and 4 in Mungama, at days 14, 28, and 42, respectively. Single- and multi-drug resistance in Nicoadala district, Zambezia province, is thus here confirmed. This should be considered when choosing control options.

Indexed as

AnimalsCattleCattle DiseasesCross-Sectional StudiesDiminazeneDrug Resistance, MultipleMozambiquePhenanthridinesPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthTrypanocidal AgentsTrypanosoma congolenseTrypanosomiasis, AfricanDiminazeneisometamidium chloridePhenanthridinesTrypanocidal AgentsAfrican animal trypanosomosisBlock treatmentChemo-resistancePCR-RFLPTrypanocides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.